Geeta Gulati

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch et al. · European Heart Journal · 2022 · 2.8K citations · Full text

Medicine, Hematology, Oncology +17

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol

Geeta Gulati, Siri Lagethon Heck, Anne Hansen Ree et al. · European Heart Journal · 2016 · 685 citations · Full text

Medicine, Oncology, Pharmacology +17

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch et al. · European Heart Journal - Cardiovascular Imaging · 2022 · 491 citations · Full text

Medicine, Hematology, Oncology +17

2025 ESC Guidelines for the management of myocarditis and pericarditis

Jeanette Schulz‐Menger, Valentino Collini, Jan Gröschel et al. · European Heart Journal · 2025 · 262 citations · Full text

Medicine, Cardiology, Internal Medicine +14

Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol

Siri Lagethon Heck, Albulena Mecinaj, Anne Hansen Ree et al. · Circulation · 2021 · 152 citations · Full text

Medicine, Oncology, Pharmacology +16